Compare VCIG & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VCIG | SINT |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 11.7M |
| IPO Year | 2022 | 2007 |
| Metric | VCIG | SINT |
|---|---|---|
| Price | $9.20 | $2.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | ★ 1.0M | 31.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,887,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $80.00 |
| P/E Ratio | $1.81 | ★ N/A |
| Revenue Growth | N/A | ★ 9.90 |
| 52 Week Low | $0.20 | $1.72 |
| 52 Week High | $15.45 | $6.78 |
| Indicator | VCIG | SINT |
|---|---|---|
| Relative Strength Index (RSI) | 96.34 | 38.90 |
| Support Level | $0.75 | $2.44 |
| Resistance Level | $15.45 | $3.01 |
| Average True Range (ATR) | 0.25 | 0.17 |
| MACD | 0.57 | 0.01 |
| Stochastic Oscillator | 82.08 | 37.03 |
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.